ABcann Global Announces Closing of Qualifying Transaction and Concurrent Financings
03 mai 2017 11h06 HE
|
ABcann Medicinals
NAPANEE, Ontario, May 03, 2017 (GLOBE NEWSWIRE) -- ABCANN GLOBAL CORPORATION (TSX-V:ABCN) (formerly Panda Capital Inc.) (“ABcann” or the “Company”) is pleased to announce that it has completed its...
Panda and ABcann Medicinals Announce Multi-Stage Product Testing Methodology
24 avr. 2017 09h00 HE
|
ABcann Medicinals
OTTAWA, April 24, 2017 (GLOBE NEWSWIRE) -- Panda Capital Inc. (NEX:PDA.H) (the “Company”) is pleased to announce details of the multi-stage product testing methodology at ABcann Medicinals Inc....